Breast Biopsy Devices Market by Procedure Type, Product, and Guidance Type - Global Industry Analysis and Forecast to 2022

Published On : October 2017 Pages : 127 Category: Medical Devices Report Code : CM10250

Industry Outlook and Trend Analysis

The Breast Biopsy Device Market was worth USD 0.38 billion in the year 2012 and is expected to reach approximately USD 1.03 billion by 2022, while registering itself at a significant compound annual growth rate (CAGR) of 9.39% during the forecast period. It is a diagnostic method that includes the expulsion of fluid or tissue from a suspicious region. The test needs working with guidance systems, the intent behind which is to detect an abnormality or a lump from the breast area. The varied modalities utilized as controlling systems in the location of breast tumors incorporate the ultrasound, mammography, and magnetic resonance imaging. The ultrasound section is foreseen to witness the quickest development attributable to the increasing requirement of non-radiation biopsies alongside the increasing interest for minimally invasive techniques. The expansion in the recurrence of breast cancers in women worldwide, and in addition the ascent in awareness of cancer screening programs is a portion of the components that are assessed to add to the market development over the gauged time frame. Furthermore, the various kinds of product improvement, ceaselessly propelled in the market are additionally anticipated that would positively affect this industry amid the estimated time frame. For example, C.R Bard's Mission Truguide disposable coaxial biopsy needles, made of ultrathin walls, give high effectiveness and precision in the securing of sample tissue. Nonetheless, the dangers engaged with the methodology are probably going to influence the Breast Biopsy Device Market contrarily. The level of hazard considers the invasiveness of the method utilized. Surgical core methods may be more precise and successful however it includes real dangers. Besides, roughly 60%to 80% of the biopsies acquired are generous. Subsequently, women are urged to take a second opinion before experiencing any such surgical strategies, which thusly is relied upon to contrarily influence the market development.

Procedure Type Outlook and Trend Analysis

Based on the type of the procedure, this market industry is categorized into open surgical and needle breast biopsies. The latter is additionally classified into core-needle biopsy, fine-needle biopsy and vacuum-assisted Biopsy. Owing to the ascending demand for minimally invasive procedures, in 2015 the fine-needle aspiration segment was accountable for a greater marker share. Fine-needle aspiration biopsy is the simplest form of breast biopsy done and mostly performed to rule out lump which can be felt at the time of clinical breast exam. The procedure involves thin needle (with syringe) being directly injected into the lump to collect cell samples. On the other hand, due to the less-invasive nature of the procedure, the vacuum-assisted core biopsy is expected to bud at a considerable higher CAGR during the forecast period. The procedure involves a minor incision through which the needle is injected, following which the sample is collected with the help of a vacuum-powered device. Also, core-needle biopsy is gradually being performed more as a breast biopsy and is anticipated to stay predominant sub-segment as compared to others. Owing to the invasiveness of open surgical breast biopsy, which are of two types, i.e., incisional and excisional breast biopsies, these procedures are less preferred unless in extreme cases. Incisional biopsy extracts a particular part from the suspicious area which is sufficient for diagnosis. Whereas, excisional biopsy removes complete part of the abnormal, tumor area, either with or without taking an edge of the normal breast tissue.

Product Outlook and Trend Analysis

The key products utilized for breast biopsy are guidance systems, localization wires, biopsy tables and needles among others. In 2015, the needles segment possessed a major share. This development is accountable to its wide relevance in the needle breast biopsy market. A large portion of the developments and progressions are seen in the products section. For example, the Stryker PreciseCore needle lets sample collection with higher accuracy and with far less risks of tissue damage included. Moreover, the guidance system product section is foreseen to witness a high development rate amid the projected time frame. In needles, the fine needle aspiration makes use of a very small needle to remove cells or liquid from the abnormal part and the core needle make the use of a big hollow needle to extract one sample of the breast in every insertion. In localization wires a guide wire is put into the suspicious part to assist the surgeon to detect the lesion for surgical biopsy.

Guidance Type Outlook and Trend Analysis

The biopsy methods require guidance systems to find the irregularity or lumps in the breast area. The accessible guiding systems utilized for biopsies incorporate the magnetic resonance guided biopsies, ultrasound-guided, and mammography-guided stereotactic among others that guide with the technique in identifying and finding the existence of unusual cell developments. The mammography-guided portion adds to the biggest share in the industry. Nonetheless, the likelihood of false positive outcomes related with the imaging of breast tissues that are dense is generally high. The ultrasound-guided method yields more exact outcomes and is foreseen to witness the most striking development rate amid the forecast period.

Regional Outlook and Trend Analysis

North America is accountable for a bigger market share, primarily due to existence of key market players and prompts adoption of enhanced medical technologies, especially in countries like Canada and the U.S. According to a non-profit organization which emphasizes on breast cancer awareness – Susang Komen, in 2015 there were more than 2.3 million breast cancer cases that were diagnosed in the United States alone. Asia Pacific region is anticipated to gain lucrative market during the forecast period. This is due to the increased level of awareness amongst the population, rising disposable income, and large population. International Association of Cancer Registries stated that in 2012, more than 600,000 fresh cases of breast cancer were diagnosed in Asia and that accounted for 39% of overall breast cancers diagnosed across the world. In EU-28 of The European Breast Cancer Coalition, it has been stated that in 2012, 361,600 breast cancer cases were registered. Also, one in every eight women in the EU-28 is expected to acquire breast cancer before the age of 85.

Competitive Insights

Some major players in the market are Devicor Medicals Products, Inc, C. R. Bard, Inc., OncoCyte Corporation, Stryker International, Inc., Dickinson and Company (BD), F. Hoffmann-La Roche Ltd., Hologic Inc, and Laboratory Corporation of America Holdings (Labcorp). These organizations are extensively inclined in the enhancement of new products, decreasing the cost of production and in implementing strategies like approvals from the Food and Drug Administration, acquisitions and mergers in order to upkeep their position in the industry. For example, Hologic, Inc declared its approval from the Food and Drug Administration for the Affirm Prone biopsy system that is commercially available. The new product is a guided system that is equipped with 2D/3D imaging characteristics.

The global Breast Biopsy Devices market is segmented as follows:

By Procedure Type

  • Needle Breast Biopsy
  • Core-needle Biopsy
  • Fine-needle Aspiration Biopsy
  • Vacuum-assisted Biopsy
  • Open Surgical Breast Biopsy
  • Excisional Breast Biopsy
  • Incisional Breast Biopsy

By Product

  • Guidance Systems
  • Biopsy Tables
  • Localization Wires
  • Biopsy Needles
  • Others (Punches, Markers, Sutures)

By Guidance Type

  • Ultrasound-guided Breast Biopsy
  • Mammography-guided Stereotactic Breast Biopsy
  • Magnetic Resonance-guided Breast Biopsy
  • Others (thermography, PET)

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2012 and forecast from 2013 to 2022?
  • What will be the industry market growth from 2012 to 2022?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

  • Breast Biopsy Device Market, By Procedure Type, Estimates and Forecast, 2012-2022 ($Million)
    • Needle Breast Biopsy
      • Core-needle Biopsy
      • Fine-needle Aspiration Biopsy
      • Vacuum-assisted Biopsy
    • Open Surgical Breast Biopsy
      • Excisional Breast Biopsy
      • Incisional Breast Biopsy
  • Breast Biopsy Device Market, By Product, Estimates and Forecast, 2012-2022 ($Million)
    • Guidance Systems
    • Biopsy Tables
    • Localization Wires
    • Biopsy Needles
    • Other Products
  • Breast Biopsy Device Market, By Guidance Type, Estimates and Forecast, 2012-2022 ($Million)
  • Ultrasound-guided Breast Biopsy
  • Mammography-guided Stereotactic Breast Biopsy
  • Magnetic Resonance-guided Breast Biopsy
  • Other Guidance Types
  • Breast Biopsy Device Market, By Region, Estimates and Forecast, 2012-2022 ($Million)
    • North America
  • North America Breast Biopsy Device Market, By Country
  • North America Breast Biopsy Device Market, By Procedure Type
  • North America Breast Biopsy Device Market, By Product
  • North America Breast Biopsy Device Market, By Guidance Type
    • U.S. Breast Biopsy Device Market, By Procedure Type
    • U.S. Breast Biopsy Device Market, By Product
    • U.S. Breast Biopsy Device Market, By Guidance Type
    • Canada Breast Biopsy Device Market, By Procedure Type
    • Canada Breast Biopsy Device Market, By Product
    • Canada Breast Biopsy Device Market, By Guidance Type
    • Mexico Breast Biopsy Device Market, By Procedure Type
    • Mexico Breast Biopsy Device Market, By Product
    • Mexico Breast Biopsy Device Market, By Guidance Type
    • Europe
  • Europe Breast Biopsy Device Market, By Country
  • Europe Breast Biopsy Device Market, By Procedure Type
  • Europe Breast Biopsy Device Market, By Product
  • Europe Breast Biopsy Device Market, By Guidance Type
    • Germany Breast Biopsy Device Market, By Procedure Type
    • Germany Breast Biopsy Device Market, By Product
    • Germany Breast Biopsy Device Market, By Guidance Type
    • France Breast Biopsy Device Market, By Procedure Type
    • France Breast Biopsy Device Market, By Product
    • France Breast Biopsy Device Market, By Guidance Type
    • UK Breast Biopsy Device Market, By Procedure Type
    • UK Breast Biopsy Device Market, By Product
    • UK Breast Biopsy Device Market, By Guidance Type
    • Italy Breast Biopsy Device Market, By Procedure Type
    • Italy Breast Biopsy Device Market, By Product
    • Italy Breast Biopsy Device Market, By Guidance Type
    • Spain Breast Biopsy Device Market, By Procedure Type
    • Spain Breast Biopsy Device Market, By Product
    • Spain Breast Biopsy Device Market, By Guidance Type
    • Rest of Europe Breast Biopsy Device Market, By Procedure Type
    • Rest of Europe Breast Biopsy Device Market, By Product
    • Rest of Europe Breast Biopsy Device Market, By Guidance Type
    • Asia-Pacific
      • Asia-Pacific Breast Biopsy Device Market, By Country
      • Asia-Pacific Breast Biopsy Device Market, By Procedure Type
      • Asia-Pacific Breast Biopsy Device Market, By Product
      • Asia-Pacific Breast Biopsy Device Market, By Guidance Type
        • Japan Breast Biopsy Device Market, By Procedure Type
        • Japan Breast Biopsy Device Market, By Product
        • Japan Breast Biopsy Device Market, By Guidance Type
        • Australia Breast Biopsy Device Market, By Procedure Type
        • Australia Breast Biopsy Device Market, By Product
        • Australia Breast Biopsy Device Market, By Guidance Type
        • India Breast Biopsy Device Market, By Procedure Type
        • India Breast Biopsy Device Market, By Product
        • India Breast Biopsy Device Market, By Guidance Type
        • South Korea Breast Biopsy Device Market, By Procedure Type
        • South Korea Breast Biopsy Device Market, By Product
        • South Korea Breast Biopsy Device Market, By Guidance Type
        • Rest of Asia-Pacific Breast Biopsy Device Market, By Procedure Type
        • Rest of Asia-Pacific Breast Biopsy Device Market, By Product
        • Rest of Asia-Pacific Breast Biopsy Device Market, By Guidance Type
    • Rest of the World
      • Rest of the World Breast Biopsy Device Market, By Country
      • Rest of the World Breast Biopsy Device Market, By Procedure Type
      • Rest of the World Breast Biopsy Device Market, By Product
      • Rest of the World Breast Biopsy Device Market, By Guidance Type
        • Brazil Breast Biopsy Device Market, By Procedure Type
        • Brazil Breast Biopsy Device Market, By Product
        • Brazil Breast Biopsy Device Market, By Guidance Type
        • South Africa Breast Biopsy Device Market, By Procedure Type
        • South Africa Breast Biopsy Device Market, By Product
        • South Africa Breast Biopsy Device Market, By Guidance Type
        • Saudi Arabia Breast Biopsy Device Market, By Procedure Type
        • Saudi Arabia Breast Biopsy Device Market, By Product
        • Saudi Arabia Breast Biopsy Device Market, By Guidance Type
        • Turkey Breast Biopsy Device Market, By Procedure Type
        • Turkey Breast Biopsy Device Market, By Product
        • Turkey Breast Biopsy Device Market, By Guidance Type
        • United Arab Emirates Breast Biopsy Device Market, By Procedure Type
        • United Arab Emirates Breast Biopsy Device Market, By Product
        • United Arab Emirates Breast Biopsy Device Market, By Guidance Type
        • Others Breast Biopsy Device Market, By Procedure Type
        • Others Breast Biopsy Device Market, By Product
        • Others Breast Biopsy Device Market, By Guidance Type

Table of Contents

1.      Introduction

1.1.      Report Description

1.2.      Research Methodology

1.2.1. Secondary Research

1.2.2. Primary Research

2.      Executive Summary

2.1.      Key Highlights

3.      Market Overview

3.1.      Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2.      Market Dynamics

3.2.1. Drivers

3.2.1.1.   Rising Number of Breast Cancer Screening Programs

3.2.1.2.   Rising Demand for Minimally Invasive Surgeries

3.2.1.3.   Growing Incidence of Breast Cancer

3.2.2. Restraints

3.2.2.1.   Infection Risks Associated to Breast Biopsy Procedures

3.2.2.2.   Strict Regulatory Issues

3.2.3. Opportunities

3.2.3.1.   Technological Advancement in Breast Biopsy Procedures

4.      Breast Biopsy Devices Market, By Procedure Type

4.1.      Introduction

4.2.      Breast Biopsy Devices Market Assessment and Forecast, By Procedure Type, 2012-2022

4.3.      Needle Breast Biopsy

4.3.1. Market Assessment and Forecast, By Type, 2012-2022 ($Million)

4.3.2. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.3.3. Core-needle Biopsy

4.3.3.1.   Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.3.4. Fine-needle Aspiration Biopsy

4.3.4.1.   Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.3.5. Vacuum-assisted Biopsy

4.3.5.1.   Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.4.      Open Surgical Breast Biopsy

4.4.1. Market Assessment and Forecast, By Type, 2012-2022 ($Million)

4.4.2. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.4.3. Excisional Breast Biopsy

4.4.3.1.   Market Assessment and Forecast, By Region, 2012-2022 ($Million)

4.4.4. Incisional Breast Biopsy

4.4.4.1.   Market Assessment and Forecast, By Region, 2012-2022 ($Million)

5.      Breast Biopsy Devices Market, By Product

5.1.      Introduction

5.2.      Breast Biopsy Devices Market Assessment and Forecast, By Product, 2012-2022

5.3.      Guidance Systems

5.3.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

5.4.      Biopsy Tables

5.4.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

5.5.      Localization Wires

5.5.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

5.6.      Biopsy Needles

5.6.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

5.7.      Other Products

5.7.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

6.      Breast Biopsy Devices Market, By Guidance Type

6.1.      Introduction

6.2.      Breast Biopsy Devices Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

6.3.      Ultrasound-guided Breast Biopsy

6.3.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

6.4.      Mammography-guided Stereotactic Breast Biopsy

6.4.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

6.5.      Magnetic Resonance-guided Breast Biopsy

6.5.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

6.6.      Other Guidance Type

6.6.1. Market Assessment and Forecast, By Region, 2012-2022 ($Million)

7.      Breast Biopsy Devices Market, By Region

7.1.      Introduction

7.2.      Breast Biopsy Devices Market Assessment and Forecast, By Region, 2012-2022 ($Million)

7.3.      North America

7.3.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

7.3.2. Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.3.3. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.3.4. Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.3.4.1.   U.S.

7.3.4.1.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.3.4.1.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.3.4.1.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.3.4.2.   Canada

7.3.4.2.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.3.4.2.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.3.4.2.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.3.4.3.   Mexico

7.3.4.3.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.3.4.3.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.3.4.3.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.4.      Europe

7.4.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

7.4.2. Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.4.3. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.4.4. Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.4.4.1.   Germany

7.4.4.1.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.4.4.1.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.4.4.1.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.4.4.2.   France

7.4.4.2.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.4.4.2.2.   Market Assessment and Forecast, By Products, 2012-2022 ($Million)

7.4.4.2.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.4.4.3.   UK

7.4.4.3.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.4.4.3.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.4.4.3.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.4.4.4.   Italy

7.4.4.4.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.4.4.4.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.4.4.4.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.4.4.5.   Spain

7.4.4.5.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.4.4.5.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.4.4.5.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.4.4.6.   Rest of Europe

7.4.4.6.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.4.4.6.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.4.4.6.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.5.      Asia-Pacific

7.5.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

7.5.2. Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.5.3. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.5.4. Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.5.4.1.   Japan

7.5.4.1.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.5.4.1.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.5.4.1.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.5.4.2.   China

7.5.4.2.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.5.4.2.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.5.4.2.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.5.4.3.   Australia

7.5.4.3.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.5.4.3.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.5.4.3.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.5.4.4.   India

7.5.4.4.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.5.4.4.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.5.4.4.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.5.4.5.   South Korea

7.5.4.5.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.5.4.5.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.5.4.5.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.5.4.6.   Rest of Asia-Pacific

7.5.4.6.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.5.4.6.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.5.4.6.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.6.      Rest of the World

7.6.1. Market Assessment and Forecast, By Country, 2012-2022 ($Million)

7.6.2. Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.6.3. Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.6.4. Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.6.4.1.   Brazil

7.6.4.1.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.6.4.1.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.6.4.1.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.6.4.2.   Turkey

7.6.4.2.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.6.4.2.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.6.4.2.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.6.4.3.   Saudi Arabia

7.6.4.3.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.6.4.3.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.6.4.3.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.6.4.4.   South Africa

7.6.4.4.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.6.4.4.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.6.4.4.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.6.4.5.   United Arab Emirates

7.6.4.5.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.6.4.5.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.6.4.5.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

7.6.4.6.   Others

7.6.4.6.1.   Market Assessment and Forecast, By Procedure Type, 2012-2022 ($Million)

7.6.4.6.2.   Market Assessment and Forecast, By Product, 2012-2022 ($Million)

7.6.4.6.3.   Market Assessment and Forecast, By Guidance Type, 2012-2022 ($Million)

8.      Company Profiles

8.1.      C. R. Bard, Inc.

8.1.1. Business Overview

8.1.2. Product Portfolio

8.1.3. Key Financials

8.1.4. Strategic Developments

8.2.      Becton, Dickinson and Company (BD)

8.2.1. Business Overview

8.2.2. Product Portfolio

8.2.3. Key Financials

8.2.4. Strategic Developments

8.3.      Hologic, Inc.

8.3.1. Business Overview

8.3.2. Product Portfolio

8.3.3. Key Financials

8.3.4. Strategic Developments

8.4.      Devicor Medical Products, Inc.

8.4.1. Business Overview

8.4.2. Product Portfolio

8.4.3. Key Financials

8.4.4. Strategic Developments

8.5.      Stryker International, Inc.

8.5.1. Business Overview

8.5.2. Product Portfolio

8.5.3. Key Financials

8.5.4. Strategic Developments

8.6.      Argon Medical Devices, Inc.

8.6.1. Business Overview

8.6.2. Product Portfolio

8.6.3. Strategic Developments

8.7.      Cook Medical, Inc.

8.7.1. Business Overview

8.7.2. Product Portfolio

8.7.3. Strategic Developments

8.8.      Scion Medical Technologies, LLC.

8.8.1. Business Overview

8.8.2. Product Portfolio

8.8.3. Strategic Developments

8.9.      PLANMED OY

8.9.1. Business Overview

8.9.2. Product Portfolio

8.9.3. Strategic Developments

8.10.   OncoCyte Corporation

8.10.1.    Business Overview

8.10.2.    Product Portfolio

8.10.3.    Key Financials

8.10.4.    Strategic Developments

8.11.   F. Hoffmann-La Roche Ltd

8.11.1.    Business Overview

8.11.2.    Product Portfolio

8.11.3.    Key Financials

8.11.4.    Strategic Developments

8.12.   Laboratory Corporation of America® Holdings.

8.12.1.    Business Overview

8.12.2.    Product Portfolio

 

8.12.3.    Strategic Developments


List of Tables

Table 1.Breast Biopsy Devices Market, By Procedure Type ($Million), 2012-2022
Table 2.Needle Breast Biopsy Market, By Region ($Million), 2012-2022
Table 3.Core-needle Biopsy Market, By Region ($Million), 2012-2022
Table 4.Fine-needle Aspiration Biopsy Market, By Region ($Million), 2012-2022
Table 5.Vacuum-assisted Biopsy Market, By Region ($Million), 2012-2022
Table 6.Open Surgical Breast Biopsy Market, By Region ($Million), 2012-2022
Table 7.Excisional Breast Biopsy Market, By Region ($Million), 2012-2022
Table 8.Incisional Breast Biopsy Market, By Region ($Million), 2012-2022
Table 9.Breast Biopsy Devices Market, By Product ($Million), 2012-2022
Table 10.Guidance Systems Market, By Region ($Million), 2012-2022
Table 11.Biopsy Tables Market, By Region ($Million), 2012-2022
Table 12.Localization Wires Market, By Region ($Million), 2012-2022
Table 13.Biopsy Needles Market, By Region ($Million), 2012-2022
Table 14.Other Products Market, By Region ($Million), 2012-2022
Table 15.Breast Biopsy Devices Market, By Guidance Type ($Million), 2012-2022
Table 16.Ultrasound-guided Breast Biopsy Market, By Region ($Million), 2012-2022
Table 17.Mammography-guided Stereotactic Breast Biopsy Market, By Region ($Million), 2012-2022
Table 18.Magnetic Resonance-guided Breast Biopsy Market, By Region ($Million), 2012-2022
Table 19.Other Guidance Types Market, By Region ($Million), 2012-2022
Table 20.Breast Biopsy Devices Market, By Region ($Million), 2012-2022
Table 21.North America Breast Biopsy Devices Market, By Country, 2012-2022 ($Million)
Table 22.North America Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 23.North America Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 24.North America Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 25.U.S. Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 26.U.S. Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 27.U.S. Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 28.Canada Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 29.Canada Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 30.Canada Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 31.Mexico Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 32.Mexico Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 33.Mexico Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 34.Europe Breast Biopsy Devices Market, By Country, 2012-2022 ($Million)
Table 35.Europe Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 36.Europe Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 37.Europe Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 38.Germany Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 39.Germany Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 40.Germany Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 41.France Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 42.France Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 43.France Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 44.UK Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 45.UK Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 46.UK Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 47.Italy Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 48.Italy Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 49.Italy Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 50.Spain Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 51.Spain Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 52.Spain Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 53.Rest of Europe Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 54.Rest of Europe Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 55.Rest of Europe Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 56.Asia-Pacific Breast Biopsy Devices Market, By Country, 2012-2022 ($Million)
Table 57.Asia-Pacific Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 58.Asia-Pacific Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 59.Asia-Pacific Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 60.Japan Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 61.Japan Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 62.Japan Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 63.China Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 64.China Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 65.China Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 66.Australia Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 67.Australia Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 68.Australia Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 69.India Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 70.India Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 71.India Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 72.South Korea Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 73.South Korea Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 74.South Korea Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 75.Rest of Asia-Pacific Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 76.Rest of Asia-Pacific Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 77.Rest of Asia-Pacific Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 78.Rest of the World Breast Biopsy Devices Market, By Country, 2012-2022 ($Million)
Table 79.Rest of the World Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 80.Rest of the World Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 81.Rest of the World Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 82.Brazil Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 83.Brazil Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 84.Brazil Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 85.Turkey Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 86.Turkey Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 87.Turkey Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 88.Saudi Arabia Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 89.Saudi Arabia Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 90.Saudi Arabia Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 91.South Africa Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 92.South Africa Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 93.South Africa Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 94.United Arab Emirates Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 95.United Arab Emirates Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 96.United Arab Emirates Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 97.Others Breast Biopsy Devices Market, By Procedure Type, 2012-2022 ($Million)
Table 98.Others Breast Biopsy Devices Market, By Product, 2012-2022 ($Million)
Table 99.Others Breast Biopsy Devices Market, By Guidance Type, 2012-2022 ($Million)
Table 100.C. R. Bard, Inc.: Key Strategic Developments, 2015-2017
Table 101.Becton, Dickinson and Company (BD): Key Strategic Developments, 2015-2017
Table 102.Hologic, Inc.: Key Strategic Developments, 2015-2017
Table 103.Devicor Medical Products, Inc.: Key Strategic Developments, 2015-2017
Table 104.Stryker International, Inc.: Key Strategic Developments, 2015-2017
Table 105.Argon Medical Devices, Inc.: Key Strategic Developments, 2015-2017
Table 106.Cook Medical, Inc.: Key Strategic Developments, 2015-2017
Table 107.Scion Medical Technologies, LLC: Key Strategic Developments, 2015-2017
Table 108.PLANMED OY: Key Strategic Developments, 2015-2017
Table 109.OncoCyte Corporation: Key Strategic Developments, 2015-2017
Table 110.F. Hoffmann-La Roche Ltd: Key Strategic Developments, 2015-2017
Table 111.Laboratory Corporation of America® Holdings: Key Strategic Developments, 2015-2017


List of Figures

Figure 1.Breast Biopsy Devices Market Share, By Procedure Type, 2012 & 2022 ($Million)
Figure 2.Breast Biopsy Devices Market, By Product, 2012 & 2022 ($Million)
Figure 3.Breast Biopsy Devices Market, By Guidance Type, 2012 & 2022 ($Million)
Figure 4.Breast Biopsy Devices Market, By Region, 2016, ($Million)
Figure 5.C. R. Bard, Inc.: Net Revenues, 2014-2016 ($Million)
Figure 6.C. R. Bard, Inc.: Net Revenue Share, By Segment, 2016
Figure 7.C. R. Bard, Inc.: Net Revenue Share, By Geography, 2016
Figure 8.Becton, Dickinson and Company (BD): Net Revenues, 2014-2016 ($Million)
Figure 9.Becton, Dickinson and Company (BD): Net Revenue Share, By Segment, 2016
Figure 10.Becton, Dickinson and Company (BD): Net Revenue Share, By Geography, 2016
Figure 11.Hologic, Inc.: Net Revenues, 2014-2016 ($Million)
Figure 12.Hologic, Inc.: Net Revenue Share, By Segment, 2016
Figure 13.Hologic, Inc.: Net Revenue Share, By Geography, 2016
Figure 14.Devicor Medical Products, Inc.: Net Revenues, 2014-2016 ($Million)
Figure 15.Devicor Medical Products, Inc.: Net Revenue Share, By Segment, 2016
Figure 16.Devicor Medical Products, Inc.: Net Revenue Share, By Geography, 2016
Figure 17.Stryker International, Inc.: Net Revenues, 2014-2016 ($Million)
Figure 18.Stryker International, Inc.: Net Revenue Share, By Segment, 2016
Figure 19.Stryker International, Inc.: Net Revenue Share, By Geography, 2016
Figure 20.OncoCyte Corporation, Inc.: Net Revenues, 2014-2016 ($Million)
Figure 21.OncoCyte Corporation, Inc.: Net Revenue Share, By Segment, 2016
Figure 22.OncoCyte Corporation, Inc.: Net Revenue Share, By Geography, 2016
Figure 23.F. Hoffmann-La Roche Ltd, Inc.: Net Revenues, 2014-2016 ($Million)
Figure 24.F. Hoffmann-La Roche Ltd, Inc.: Net Revenue Share, By Segment, 2016
Figure 25.F. Hoffmann-La Roche Ltd, Inc.: Net Revenue Share, By Geography, 2016

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*